Examining Critical Gaps in AF Stroke Prevention – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Alexander Benz et al, adding:
“Antithrombotic Therapy in Patients with Atrial Fibrillation: Unresolved Issues and Future Directions
This review examines critical gaps in AF stroke prevention, including limitations of current risk scores, populations where vitamin K antagonists remain preferred, uncertain net benefit in special groups, and the emerging promise of factor XI inhibitors for safer anticoagulation.”
Title: Antithrombotic therapy in patients with atrial fibrillation: unresolved issues and future directions
Authors: Alexander Benz, Stephanie Carlin, John Eikelboom
Read the Full Article on JTH
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 21, 2026, 11:02Severe ITP, Critical Bleeding, and the Challenge of Platelet Testing – RPTH Journal
-
Aug 21, 2026, 10:46Arwa Z. Al-Riyami: Looking Ahead to ISBT Muscat 2029
-
Aug 21, 2026, 10:42Janine Mothershed: What Is Romiplostim and How Does It Work in Immune Thrombocytopenia?
-
Aug 21, 2026, 10:33Omar Alkharabsheh: Excited to Build the Future of Hematologic Malignancy Care in Central Florida
-
Aug 21, 2026, 10:23Salvador Payán Pernía: Tailoring Therapy in Sickle Cell Disease – Mitapivat and the Path Toward Personalized Combination Care
-
Aug 21, 2026, 10:10Pete Stibbs: The Evolving Landscape of VTE Management
-
Aug 21, 2026, 09:58Nishant K Mishra։ When Epilepsy Meets Anticoagulation
-
Aug 21, 2026, 09:07Sujal Lohana: Building a Better Blood Donor–Seeker App
-
Aug 21, 2026, 08:55Robert Sidonio: Connecting Experts in Bleeding and Clotting Disorders